Annual Total Liabilities
$75.17 M
+$60.41 M+409.07%
31 December 2023
Summary:
NKGen Biotech Common Stock annual total liabilities is currently $75.17 million, with the most recent change of +$60.41 million (+409.07%) on 31 December 2023. NKGN annual total liabilities is now at all-time high.NKGN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$85.36 M
+$13.99 M+19.61%
30 June 2024
Summary:
NKGen Biotech Common Stock quarterly total liabilities is currently $85.36 million, with the most recent change of +$13.99 million (+19.61%) on 30 June 2024. Over the past year, it has increased by +$19.53 million (+29.66%). NKGN quarterly total liabilities is now at all-time high.NKGN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKGN Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +409.1% | +29.7% |
3 y3 years | - | - |
5 y5 years | - | - |
NKGN Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +409.1% | at high | +478.1% |
5 y | 5 years | at high | +409.1% | at high | +478.1% |
alltime | all time | at high | +409.1% | at high | +478.1% |
NKGen Biotech Common Stock Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $85.36 M(+19.6%) |
Mar 2024 | - | $71.37 M(-5.1%) |
Dec 2023 | $75.17 M | $75.17 M(+14.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2023 | - | $65.84 M(+96.8%) |
June 2023 | - | $33.46 M(+126.6%) |
Dec 2022 | $14.77 M(-73.7%) | $14.77 M |
Dec 2021 | $56.12 M | - |
FAQ
- What is NKGen Biotech Common Stock annual total liabilities?
- What is the all time high annual total liabilities for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock annual total liabilities year-on-year change?
- What is NKGen Biotech Common Stock quarterly total liabilities?
- What is the all time high quarterly total liabilities for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock quarterly total liabilities year-on-year change?
What is NKGen Biotech Common Stock annual total liabilities?
The current annual total liabilities of NKGN is $75.17 M
What is the all time high annual total liabilities for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high annual total liabilities is $75.17 M
What is NKGen Biotech Common Stock annual total liabilities year-on-year change?
Over the past year, NKGN annual total liabilities has changed by +$60.41 M (+409.07%)
What is NKGen Biotech Common Stock quarterly total liabilities?
The current quarterly total liabilities of NKGN is $85.36 M
What is the all time high quarterly total liabilities for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high quarterly total liabilities is $85.36 M
What is NKGen Biotech Common Stock quarterly total liabilities year-on-year change?
Over the past year, NKGN quarterly total liabilities has changed by +$19.53 M (+29.66%)